Breast Density Highest Risk Factor in Development of Breast Cancer

Article

According to the results of a study recently published in <em>JAMA Oncology,</em>&nbsp;high breast density surpasses other known risk factors for developing breast cancer, including family history of the disease, personal history of benign lesions, and later-in-life childbirth.

Karla Kerlikowske, MD

Karla Kerlikowske, MD

According to the results of a study recently published inJAMA Oncology,high breast density surpasses other known risk factors for developing breast cancer, including family history of the disease, personal history of benign lesions, and later-in-life childbirth.

Researchers at the University of California, San Francisco (UCSF) evaluated risk factors in 202,746 women—18,437 of which had varying stages of breast cancer, and 184,309 of which did not have cancer&mdash;who were enrolled in the Breast Cancer Surveillance Consortium, which is a national collaborative network of 7 mammography registries.

Overall, 4,747 (89.8%) premenopausal and 12,502 (95.1%) postmenopausal women with breast cancer had at least 1 breast cancer risk factor.

However, breast density was the most prevalent risk factor for both premenopausal and postmenopausal women. Researchers noted that 39.3% of premenopausal and 26.2% of postmenopausal breast cancers could potentially be averted if all women with heterogeneously (more than half of the tissue in the breast is dense) or extremely (dense tissue is present in more than 75% of your breast) dense breasts shifted to scattered fibroglandular (which is mostly fat with a few dense areas) breast density.

After examining these breast cancer cases, the investigators &ldquo;basically found that the risk factor that explained the development of breast cancer, in the largest number of women, was high breast density,&rdquo; Karla Kerlikowske, MD, researcher in the department of Medicine and Epidemiology and Biostatistics at UCSF and senior author on the study, said in an interview withOncLive. &ldquo;Breast density is a common and strong risk factor, so it contributes a lot to the development of breast cancer.&rdquo;

The study also reinforced the fact that obesity can increase the odds of a woman developing breast cancer. Among postmenopausal women, 22.8% of breast cancers could potentially be averted if all overweight and obese women attained a body mass index of less than 25, noted the authors.

&ldquo;We can do something about obesity by choosing healthy foods and exercise,&rdquo; she said. &ldquo;Breast density is also modifiable. Women who are very high-risk can take tamoxifen. Breast feeding is also thought to lower breast density, and the younger people are when they have their children and the more children they have also lowers breast density.&rdquo;

Dense breasts make it more difficult for radiologists to see cancer on a mammogram. The American Cancer Society states that dense tissue may mask a mass or tumor because both look white on the mammogram.

Kerlikowske believes that breast density leads to breast cancer because of high cellular content in the breasts, as well as the communication between the epithelial cells and stroma tissue.

She added that physicians and researchers should be using risk prediction models to try to identify women who are at risk of invasive breast cancer.

Common factors associated with breast cancer, such as first-degree family history, a history of benign breast biopsy and delaying childbirth until after age 30, each accounted for less than 10% of cases in the population studied.

Kerlikowske said it is important for women to understand and pay attention to their bodies for any potential risk factors that could be associated with developing breast cancer.

&ldquo;We found that at least 90% of the women who had breast cancer had at least one of the risk factors we looked at,&rdquo; she said. &ldquo;So, I think knowing your risk factors and discussing those with your primary provider, and then use our risk calculator, which includes breast density, to calculate the risk.&rdquo;

Related Videos
Video 6 - "Current Approaches to Treatment Sequencing in HER2+ Breast Cancer"
Video 5 - "Exciting Developments in HER2+ Breast Cancer"
Video 4 - "KATHERINE: Adjuvant T-DM1 vs Trastuzumab for Residual Invasive HER2+ Breast Cancer"
Video 3 - "APHINITY Trial: Pertuzumab for Patients with HER2+ Breast Cancer"
Rebecca A. Shatsky, MD, an expert on breast cancer
Rebecca A. Shatsky, MD, an expert on breast cancer
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
Related Content